Twist Bioscience Corporation (TWST)
Largest Insider Buys in Sector
TWST Stock Price History Chart
TWST Stock Performance
About Twist Bioscience Corporation
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical …
Insider Activity of Twist Bioscience Corporation
Over the last 12 months, insiders at Twist Bioscience Corporation have bought $0 and sold $6.6M worth of Twist Bioscience Corporation stock.
On average, over the past 5 years, insiders at Twist Bioscience Corporation have bought $191,048 and sold $62.19M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $132,000 was made by Cho Dennis (See Remarks) on 2023‑05‑10.
List of Insider Buy and Sell Transactions, Twist Bioscience Corporation
| 2024-11-11 | Sale | Chief Executive Officer | 7,968 0.0138% | $48.00 | $382,448 | -10.13% | ||
| 2024-11-11 | Sale | President and COO | 10,340 0.0179% | $48.00 | $496,299 | -10.13% | ||
| 2024-11-11 | Sale | SVP of Human Resources | 1,347 0.0023% | $48.00 | $64,653 | -10.13% | ||
| 2024-11-11 | Sale | See Remarks | 1,507 0.0026% | $48.00 | $72,333 | -10.13% | ||
| 2024-11-11 | Sale | director | 3,600 0.0062% | $47.26 | $170,139 | -10.13% | ||
| 2024-11-06 | Sale | Chief Executive Officer | 14,334 0.0243% | $44.60 | $639,368 | -0.20% | ||
| 2024-11-06 | Sale | President and COO | 6,239 0.0106% | $44.60 | $278,291 | -0.20% | ||
| 2024-11-06 | Sale | SVP of Human Resources | 5,519 0.0093% | $44.60 | $246,175 | -0.20% | ||
| 2024-11-06 | Sale | See Remarks | 1,811 0.0031% | $44.60 | $80,780 | -0.20% | ||
| 2024-11-06 | Sale | Chief Financial Officer | 4,160 0.007% | $44.60 | $185,557 | -0.20% | ||
| 2024-11-06 | Sale | Chief Accounting Officer | 1,448 0.0025% | $44.60 | $64,588 | -0.20% | ||
| 2024-11-04 | Sale | Chief Executive Officer | 4,841 0.008% | $41.56 | $201,211 | +7.97% | ||
| 2024-11-04 | Sale | President and COO | 2,681 0.0044% | $41.56 | $111,433 | +7.97% | ||
| 2024-11-04 | Sale | SVP of Human Resources | 1,057 0.0017% | $41.56 | $43,933 | +7.97% | ||
| 2024-11-04 | Sale | See Remarks | 659 0.0011% | $41.56 | $27,391 | +7.97% | ||
| 2024-11-04 | Sale | Chief Accounting Officer | 156 0.0003% | $41.56 | $6,484 | +7.97% | ||
| 2024-10-23 | Sale | President and COO | 2,261 0.0038% | $43.09 | $97,429 | 0.00% | ||
| 2024-10-09 | Sale | Chief Financial Officer | 856 0.0013% | $41.81 | $35,791 | +8.96% | ||
| 2024-10-02 | Sale | Chief Executive Officer | 13,605 0.0213% | $43.21 | $587,886 | +0.14% | ||
| 2024-10-02 | Sale | President and COO | 6,865 0.0108% | $43.21 | $296,644 | +0.14% |
Insider Historical Profitability
| Cho Dennis | See Remarks | 91163 0.1556% | $41.01 | 1 | 17 | +82.06% |
| ARCH Venture Partners VIII, LLC | 10 percent owner | 2407422 4.1092% | $41.01 | 1 | 0 | +78.29% |
| BARTHELEMY NICOLAS | 13939 0.0238% | $41.01 | 1 | 1 | +9.24% | |
| CRANDELL KEITH | director | 486 0.0008% | $41.01 | 1 | 2 | +78.29% |
Institutional Investor Ownership
| ARK Investment Management LLC | $238.25M | 11.93 | 6.94M | -3.73% | -$9.24M | 0.82 | |
| BlackRock | $198.14M | 9.92 | 5.77M | -2.9% | -$5.92M | <0.01 | |
| The Vanguard Group | $187.41M | 9.38 | 5.46M | -0.24% | -$449,117.90 | <0.01 | |
| Artisan Partners | $159.25M | 7.97 | 4.64M | +24.66% | +$31.51M | 0.24 | |
| JPMorgan Chase | $123.99M | 6.21 | 3.61M | -21.71% | -$34.38M | 0.01 |